March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Get basic information about HIV drug resistance – what it is, what causes it, testing for it, and how to prevent it from developing.
Get basic information about tests for resistance, tropism, and viral load – what they are, when you need them, and how they are used.